Skin preparations

JP7634217B2Active Publication Date: 2025-02-21TECHNOBLE +1
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2020123905
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2020-07-20
Publication Date
2025-02-21
Estimated Expiration
2040-07-20

AI Technical Summary

Benefits of technology

【0007】 本発明は、精米歩合90%以上の米糠の蛋白質分解酵素処理物を有効成分とする皮膚外用剤であって、その有効成分が有する蛋白質の糖化の発生を抑制作用及び酸化蛋白質分解酵素の活性化作用に基づき、細胞環境を健全化する皮膚外用剤を提供することができる。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007634217000001
    Figure 0007634217000001
  • Figure 0007634217000002
    Figure 0007634217000002
Patent Text Reader

Abstract

To provide an external preparation for skin which is derived from a natural product, has excellent biological safety, and includes an active ingredient which improves a cell environment on the basis of an effect of removing protein damaged by oxidation reaction in an organism.SOLUTION: An external preparation for skin has a protease-processed product of rice bran with a polishing percentage of 90% or more as an active ingredient.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a functional material derived from rice bran that removes proteins damaged by oxidation reactions in the body, and to an external skin preparation containing the same. [Background technology]

[0002] It has been known that the function of cells declines when proteins in cells are oxidized or glycated due to factors such as sunlight (ultraviolet rays), active oxygen, and chemicals in the air. It has been suggested that this phenomenon occurring in skin cells may cause dryness or dullness of the skin. For this reason, ingredients for cosmetics that prevent protein glycation in skin cells have been proposed.

[0003] However, these conventional ingredients have problems in terms of safety to the body, such as the skin, and effectiveness when actually applied to the body. For example, Patent Documents 1 and 2 disclose anti-glycation ingredients derived from rice or rice bran, but there is a demand for more effective ingredients.

[0004] [Patent Document 1] Patent Publication No. 2010-209003 [Patent Document 2] Patent Publication No. 2018-095618 DISCLOSURE OF THEINVENTION [Problem to be solved by the invention]

[0005] In view of the problems associated with the conventional technology, the inventors have newly discovered that proteolytic enzyme-treated rice bran has the effect of suppressing the occurrence of protein glycation and enhancing the enzymatic activity that breaks down oxidized proteins, and have thus completed the present invention. [Means for solving the problem]

[0006] The present invention is a skin care product containing, as an active ingredient, rice bran with a polishing rate of 90% or more treated with a proteolytic enzyme. Effect of the Invention

[0007] The present invention provides an external skin preparation containing as an active ingredient a protease-treated product of rice bran with a polishing ratio of 90% or more, which has the effect of inhibiting the occurrence of protein glycation and activating oxidative protease, thereby making it possible to provide an external skin preparation that improves the cellular environment. [Brief description of the drawings]

[0008] [Figure 1] FIG. 1 is a graph showing the inhibitory effect of the protease-treated rice bran according to the present invention on the generation of advanced glycation end products (AGE). [Diagram 2] FIG. 2 is a graph showing the effect of enhancing oxidative protease activity of the protease-treated rice bran according to the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0009] From the viewpoint of effectiveness, the rice bran used in the present invention has a polishing ratio of 90% or more, and more preferably 95.0% or more. Here, the polishing ratio refers to the weight ratio of white rice (rice from which the bran, germ, and other outer layers have been removed, including white rice used to make rice koji) to brown rice (see National Tax Agency Notification No. 8, November 22, 1989, "Standards for Labeling the Manufacturing Method and Quality of Sake").

[0010] In the present invention, an extract is prepared using the above-mentioned rice bran. The preparation of the extract can be carried out by previously washing the part of each plant to be extracted with water, drying, cutting into small pieces or crushing it as necessary, and then contacting it with an extraction solvent by a conventional method such as immersion, countercurrent extraction, steam distillation, or supercritical extraction. The extract is then treated with a protease as described below.

[0011] Examples of extraction solvents include water; lower alcohols such as methanol, ethanol, and propanol; polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, and glycerin; esters such as ethyl acetate, butyl acetate, and methyl propionate; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; and hydrocarbon solvents such as n-hexane, toluene, and chloroform, and these can be used alone or in combination of two or more.

[0012] Among these extraction solvents, the use of water or a mixed solvent of water and a lower alcohol or a polyhydric alcohol is preferred in the present invention, since it can be widely applied to skin external preparations (cosmetics or quasi-drugs) or foods and beverages. When a mixed solvent is used, the mixing ratio of the lower alcohol or polyhydric alcohol to water is generally 70% by weight or less, preferably 50% by weight or less.

[0013] In preparing the extract, the pH, temperature and time are not particularly limited, but it is preferable to select them appropriately depending on the part of the plant to be extracted.

[0014] For example, in the present invention, when preparing a rice bran extract solution, it is preferable to adjust the pH using an alkali adjuster or acidity adjuster as appropriate. Examples of alkali adjusters include sodium salts such as sodium hydroxide and sodium carbonate, and potassium salts such as potassium hydroxide. Among these, sodium hydroxide and sodium carbonate are preferred. Examples of acidity adjusters include inorganic acids such as hydrochloric acid, sulfuric acid, and phosphoric acid, and organic acids such as acetic acid, lactic acid, malic acid, and citric acid.

[0015] The extract obtained by the above-mentioned treatment is treated with a protease before or after the extraction, or in parallel with the extraction. Examples of protease include actinases such as actinase, pepsins such as pepsin, trypsins such as trypsin and chymotrypsin, papains such as papain and chymopapain, peptidases such as glycylglycine peptidase, carboxypeptidase, and aminopeptidase, bromelain, and a complex protease derived from a microorganism [e.g., Neurase (manufactured by Amano Enzyme Co., Ltd.)]. When using a protease, any of the above enzymes may be used alone or in combination. Furthermore, a combination of enzymes such as amylolytic enzymes (e.g., α-amylase, β-amylase, glucoamylase, or β-galactosidase), cellulose decomposing enzymes (e.g., cellulase, hemicellulase, pectinase), and lipolytic enzymes (lipase, etc.) may be used before or after the treatment with the protease, or in parallel with the treatment.

[0016] The treatment using the enzyme is carried out by adding one or more of the above enzymes to the above-mentioned plant extract solution and carrying out the enzyme reaction under conditions of the optimum pH and the optimum temperature of the enzyme used. When using two or more enzymes in combination, the two or more enzymes may be allowed to act simultaneously or sequentially with or without changing the reaction conditions depending on the properties of the enzymes used. The amount of the enzyme used is preferably in the range of 0.001 to 50 parts by weight per enzyme, more preferably in the range of 0.1 to 10 parts by weight, per 100 parts by weight of the solid content of the plant extract solution. The time of the enzyme treatment varies depending on the type of enzyme used, but is generally in the range of 0.5 to 24 hours, preferably in the range of 1 to 6 hours.

[0017] After completion of the enzyme treatment using the above enzymes, the enzymes are inactivated using an appropriate method, such as heating the enzyme-treated solution to 80° C. or higher, to obtain an enzyme-treated decomposition product solution.

[0018] The protease-treated product prepared as described above may be used as a cosmetic ingredient as it is after generally adjusting the pH to 3 to 8, or may be used at a desired concentration by concentrating under reduced pressure, etc. The extract may also be dried by a conventional method such as spray drying.

[0019] When the enzyme-treated product of the present invention is incorporated into an external skin preparation, in addition to the above-mentioned enzyme-treated product as an essential component, components usually used in cosmetics, such as oily components, surfactants (synthetic and natural), moisturizers, anti-inflammatory agents, thickeners, preservatives and germicides, anti-acne agents, cell activators, powder components, ultraviolet absorbers, antioxidants, whitening agents, anti-wrinkle agents, pigments, fragrances, etc., can be appropriately incorporated as necessary.

[0020] Examples of oily components include olive oil, jojoba oil, castor oil, soybean oil, rice oil, rice germ oil, coconut oil, palm oil, cocoa oil, meadowfoam oil, shea butter, tea tree oil, avocado oil, macadamia nut oil, bergamot oil, lavender oil, rose oil, bergamot oil, chamomile oil, and other plant-derived oils and fats such as squalane; vitamin A oil; animal-derived oils and fats such as mink oil and turtle oil; waxes such as beeswax, carnauba wax, rice wax, and lanolin; liquid paraffin, petrolatum, and paraffin wax. and squalane; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid, and cis-11-eicosenoic acid; higher alcohols such as lauryl alcohol, cetanol, pantothenyl alcohol, and stearyl alcohol; synthetic esters and synthetic triglycerides such as isopropyl myristate, isopropyl palmitate, butyl oleate, 2-ethylhexyl glyceride, and higher fatty acid octyldodecyl (e.g., octyldodecyl stearate).

[0021] Examples of the surfactant include nonionic surfactants such as polyoxyethylene alkyl ethers, polyoxyethylene fatty acid esters, polyoxyethylene sorbitan fatty acid esters, glycerin fatty acid esters, polyglycerin fatty acid esters, polyoxyethylene glycerin fatty acid esters, polyoxyethylene hydrogenated castor oil, and polyoxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkylbenzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkyl phenyl ether sulfates, polyoxyethylene alkyl ether phosphates, α-sulfonated fatty acid alkyl ester salts, polyoxyethylene Examples of the surfactants that can be used include anionic surfactants such as quaternary ammonium salts, primary to tertiary fatty amine salts, trialkylbenzylammonium salts, alkylpyridinium salts, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salts, N,N-dialkylmorpholinium salts, and polyethylene polyamine fatty acid amide salts; and amphoteric surfactants such as N,N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N,N,N-trialkyl-N-alkyleneammoniocarboxybetaine, N-acylamidopropyl-N', N'-dimethyl-N'-β-hydroxypropylammoniosulfobetaine.

[0022] Examples of the emulsifier and / or emulsifier aid that can be blended include stevia derivatives such as enzyme-treated stevia, saponin or its derivatives, casein or its salts (sodium, etc.), sugar and protein complexes, sucrose or its esters, lactose, soy-derived water-soluble polysaccharides, soy-derived protein and polysaccharide complexes, lanolin or its derivatives, cholesterol, stevia derivatives (enzyme-treated stevia, etc.), silicates (aluminum, magnesium, etc.), carbonates (calcium, sodium, etc.), saponin and its derivatives, lecithin and its derivatives (hydrogenated lecithin, etc.), lactic acid bacteria-fermented rice, lactic acid bacteria-fermented germinated rice, lactic acid bacteria-fermented grains (wheat, beans, millet, etc.), etc.

[0023] Examples of moisturizing agents include glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidone carboxylate, and the like, as well as sugars such as trehalose and raffinose, mucopolysaccharides (e.g., hyaluronic acid and its derivatives, hyaluronic acid fermentation liquid, chondroitin and its derivatives, heparin and its derivatives, etc.), elastin and its derivatives, collagen and its derivatives, collagen peptides, NMF-related substances, lactic acid, urea, higher fatty acids octyldodecyl, seaweed extracts, estradiol, various amino acids and their derivatives.

[0024] Examples of thickening agents include ingredients derived from brown algae, green algae, or red algae, such as alginic acid, agar, carrageenan, and fucoidan; polysaccharides such as pectin and aloe polysaccharides; gums such as tragacanth gum, locust bean gum, xanthan gum, and guar gum; cellulose derivatives such as carboxymethyl cellulose, hydroxyethyl cellulose, and hydroxypropyl cellulose; synthetic polymers such as carboxyvinyl polymers, alkyl-modified carboxyvinyl polymers, polyvinyl alcohol, polyvinylpyrrolidone, and acrylic acid-methacrylic acid copolymers; hyaluronic acid and its derivatives; polyglutamic acid and its derivatives, and polyacrylic acid.

[0025] Anti-inflammatory agents include allantoin, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, β-glycyrrhetinic acid, stearyl glycyrrhetinate, ε-aminocaproic acid, d-camphor, dl-camphor, zinc oxide, panthenol, pyridoxine hydrochloride, and riboflavin or a derivative thereof.

[0026] Examples of preservatives and disinfectants include urea; benzoic acid or its salts, paraoxybenzoic acid esters such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate; phenoxyethanol, dichlorophene, hexachlorophene, chlorhexidine hydrochloride, benzalkonium chloride, salicylic acid, sodium salicylate, zinc pyrithione, benzalkonium chloride, ethanol, undecylenic acid, phenols, and alkane bromide. These include kilisoquinolinium, resorcinol, jamal (imidazolidinyl urea), isopropyl methylphenol, triclosan, trichlorocarbanide, trichlorohydroxydiphenol ether, hinokitiol, 1,2-pentanediol, propanediol, concentrated benzalkonium chloride solution 50, essential oils such as peppermint oil and eucalyptus oil, bark distillate, fermented radish liquid, ethanol derived from plants such as sugar cane and corn, or 1,3-butylene glycol.

[0027] Examples of cell activators include pantothenyl alcohol, menthol, dl-menthol, and γ-oryzanol.

[0028] Anti-acne agents include sulfur, salicylic acid or its salts, photosensitizer No. 201, pyridoxine dicaprylate, and the like.

[0029] Examples of powder components include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, nylon powder, polyethylene powder, silk powder, cellulose-based powder, powder of grains (rice, wheat, corn, millet, etc.), powder of beans (soybeans, adzuki beans, etc.), etc.

[0030] Examples of ultraviolet absorbers include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and its derivatives, 2-ethylhexyl paramethoxycinnamate, octyl cinnamate, oxybenzone, 2,4-dihydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 4-tert-butyl-4-methoxybenzoylmethane, 2-(2-hydroxy-5-methylphenyl)benzotriazole, urocanic acid, ethyl urocanate, and aloe extract.

[0031] Examples of antioxidants include butylhydroxyanisole, butylhydroxytoluene, propyl gallate, carotenoids such as astaxanthin, vitamin E and its derivatives (for example, tocopherol acetate, tocopherol nicotinate), vitamin A and its derivatives (retinol palmitate, etc.).

[0032] Examples of whitening agents include t-cycloamino acid derivatives, kojic acid and its derivatives, ascorbic acid and its derivatives, hydroquinone or its derivatives, ellagic acid and its derivatives, nicotinic acid and its derivatives, resorcinol derivatives, tranexamic acid and its derivatives, 4-methoxysalicylic acid potassium salt, magnolignan (5,5'-dipropyl-biphenyl-2,2'-diol), hydroxybenzoic acid and its derivatives, vitamin E and its derivatives, α-hydroxy acid, AMP (adenosine monophosphate), and the like, which may be used alone or in combination.

[0033] Examples of the kojic acid derivatives include kojic acid esters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, and kojic acid dibutyrate, kojic acid ethers, and kojic acid sugar derivatives such as kojic acid glucoside. Examples of the ascorbic acid derivatives include ascorbic acid ester salts such as sodium L-ascorbic acid 2-phosphate, magnesium L-ascorbic acid 2-phosphate, sodium L-ascorbic acid 2-sulfate, and magnesium L-ascorbic acid 2-sulfate. Ascorbic acid sugar derivatives such as ascorbic acid 2-glucoside, L-ascorbic acid 5-glucoside, ascorbyl tocopheryl maleate, ascorbyl tocopheryl phosphate K, myristyl 3-glyceryl ascorbate, and caprylyl 2-glyceryl ascorbate; 6-acylated derivatives of these ascorbic acid sugar derivatives (the acyl group is a hexanoyl group, an octanoyl group, a decanoyl group, etc.); L-ascorbic acid tetraisopalmitate, L-ascorbic acid tetralaurate, and other L-ascorbic acid tetrafatty acid esters; 3- Examples of ascorbic acid derivatives include O-ethyl ascorbic acid, L-ascorbic acid-2-phosphate-6-O-sodium palmitate, glyceryl ascorbic acid or its acylated derivatives, ascorbic acid glycerin derivatives such as bisglyceryl ascorbic acid, aminopropyl L-ascorbic acid phosphate, hyaluronic acid derivatives of L-ascorbic acid, 3-OD lactose-L-ascorbic acid, and isostearyl ascorbyl phosphate. Examples of hydroquinone derivatives include arbutin (hydroquinone-β-D-glucopyranoside), α-arbutin (hydroquinone-α-D-glucopyranoside), and Examples of the tranexamic acid derivatives include tranexamic acid esters (e.g., tranexamic acid lauryl ester, tranexamic acid hexadecyl ester, tranexamic acid cetyl ester or a salt thereof) and amides of tranexamic acid (e.g., tranexamic acid methylamide). Examples of the resorcinol derivatives include 4-n-butylresorcinol and 4-isoamylresorcinol. Examples of the 2,5-dihydroxybenzoic acid derivatives include 2,5-diacetoxybenzoic acid, 2-acetoxy-5-hydroxybenzoic acid,Examples of nicotinic acid derivatives include nicotinamide and benzyl nicotinate, and examples of α-hydroxy acids include lactic acid, malic acid, succinic acid, citric acid, and α-hydroxyoctanoic acid.

[0034] Examples of physiologically active ingredients include placenta extract, mulberry bark extract, saxifrage extract, perilla extract, rice bran extract or hydrolysate thereof, white mustard extract or hydrolysate thereof, fermented white mustard, peony extract or hydrolysate thereof, lactic acid bacteria extract, bifidobacteria extract, barley extract, lotus seed extract or hydrolysate thereof, fermented lotus seed product, Job's tears hydrolysate, fermented Job's tears seed product, fermented royal jelly product, soybean sprout extract, sake lees extract or ceramide contained therein, fermented sake lees product, Pandanus amaryllis extract, and alkangelis. Aflava extract, calendula extract, chamomile extract, coral grass extract, rice leaf extract or its hydrolysate, eggplant (lotus, long eggplant, Kamo eggplant, rice eggplant, etc.) extract or its hydrolysate, apricot fruit extract, seaweed extract such as Eucalyptus tschonoskii, extract of marine flowering plants such as Zostera marina, fermented soy milk, jellyfish water, rice extract or its hydrolysate, fermented rice extract, germinated rice extract or its hydrolysate, fermented germinated rice, black bean extract or its hydrolysate, brown sugar extract or its fermented product, Damask rose flower extract, ylang-ylang flower extract, bamboo shoot skin extract, Linoleic acid and its derivatives or processed products (e.g., liposomal linoleic acid, etc.), flavonoids or their glycosides derived from citrus plants, collagen and its derivatives derived from animals or fish, elastin and its derivatives, proteoglycan derived from animals or fish, glycyrrhizic acid and its derivatives (dipotassium salt, etc.), t-cycloamino acid derivatives, vitamin A and its derivatives, allantoin, diisopropylamine dichloroacetate, γ-amino-β-hydroxybutyric acid, gentian extract, licorice extract, ginseng extract, Panax ginseng (white ginseng) extract, Panax ginseng (white ginseng) extract, carrot fermentation product, camellia extract, Mitsuishi Kami extract, loofah extract, Ulva pertusa extract, peach extract, plum extract, peach kernel extract, kiwi extract, sunflower extract, juazeiro extract, pau d'arco bark extract, daylily extract or fermented product, hibiscus flower extract or fermented product, silverleaf extract, cherimoya extract, mango extract, mangosteen extract, funori extract, oolong tea extract, red fuki extract, Bletilla serrata extract, sweet potato extract, Japanese pepper peel or seed coat extract or hydrolysate thereof, safflower flower extract, Casablanca lily extract,Examples of such extracts include sweet potato extract or its fermented product, guava leaf extract, artemisia capillaris extract, clove extract, olive leaf extract, horse chestnut extract, ginger extract, vanilla extract, Houttuynia cordata extract, Banpeiyu extract, aloe extract, aloe vera extract, tulip extract, Centella asiatica extract, fig flower extract, apple extract, white asparagus extract, Pueraria lobata extract, and Codonopsis gracilis extract or its hydrolysate.

[0035] The application site of the skin external preparation (including cosmetics and quasi-drugs) containing the enzyme-treated product according to the present invention includes the whole skin including the scalp, and is not particularly limited.Therefore, it can be used in milky lotions, creams, lotions, essences, ointments, packs, poultices, skin cleansers (such as soaps), face washes, shampoos, rinses, treatments, body creams, lip cosmetics, various makeup cosmetics, bath agents, etc.

[0036] The present invention will now be described in more detail with reference to Production Examples, Test Examples and Formulation Examples, but the present invention is not limited thereto. In the following, all parts are by weight and all % are by weight.

[0037] Production Example 1. Preparation of Enzyme-treated Rice Bran Product (1) of the Present Invention 1500g of 0.1M lactic acid solution was added to 500g of rice bran (polished rice ratio 90%), stirred to thoroughly mix the rice bran and lactic acid solution, and then left to stand at room temperature for one day. Insoluble matter was then removed by filtration, and the filtrate was treated with papain. The enzyme treatment was carried out by using 1.2mg of enzyme, at the optimum pH for the enzyme, and keeping the mixture at 80°C for one hour. The insoluble matter resulting from the treatment was filtered off, and the filtrate was adjusted to pH 6.5 with phytic acid, yielding 730g of a pale yellow, transparent enzyme-treated rice bran solution (solids concentration 3.60%).

[0038] Production Example 2. Preparation of enzyme-treated rice bran product (2) according to the present invention 735 g of enzyme-treated rice bran solution (solid concentration 3.64%) was obtained by the same process as in Production Example 1, except that rice bran with a polishing ratio of 95% was used instead of the rice bran in Production Example 1 (polishing ratio 90%).

[0039] Comparative Manufacturing Examples 1 to 4. Preparation of enzyme-treated rice bran products for comparison Except for using rice bran with the following polishing ratios instead of the rice bran (polishing ratio 90%) in Production Example 1, enzyme-treated rice bran solutions were obtained by the same process as in Production Example 1. That is, enzyme-treated rice bran solutions were prepared as follows: Comparative Production Example 1: a rice bran enzyme-treated solution (solid concentration: 3.40%) obtained using rice bran with a polishing ratio of 10%, Comparative Production Example 2: a rice bran enzyme-treated solution (solid concentration: 3.46%) obtained using rice bran with a polishing ratio of 30%, Comparative Production Example 3: a rice bran enzyme-treated solution (solid concentration: 3.50%) obtained using rice bran with a polishing ratio of 50%, Comparative Production Example 4: a rice bran enzyme-treated solution (solid concentration: 3.53%) obtained using rice bran with a polishing ratio of 70%, respectively.

[0040] Test Example 1: Evaluation test of the effect of inhibiting the generation of advanced glycation end products (AGE) In this test, the effect of inhibiting the generation of AGE, that is, the effect of inhibiting protein glycation, was evaluated by the generation of fluorescence from BSA (bovine serum albumin) via glucose. First, 40 μL of each of the rice bran enzyme-treated products of Production Examples 1 and 2 according to the present invention and the rice bran enzyme-treated products of Comparative Production Examples 1 to 4, 40 μL of 50 mg / mL BSA aqueous solution, 40 μL of 2.5 M glucose aqueous solution, and 80 μL of PBS (-) solution were mixed and stirred to prepare a sample solution. Here, each rice bran enzyme-treated product was prepared so that the final concentration of the solution in the sample solution was 2.0%. Next, the sample solution was left to stand at 50° C. for 7 days, and after 7 days, the fluorescence generation (excitation: 355 nm, emission: 460 nm: fluorescence microplate reader (Fluoroscan Ascent, Thermo Fisher Scientific)) was measured for each sample solution. In addition, the same procedure was performed for a control in which purified water was used instead of the sample solution and no sample was added. The relative values ​​(%) of the fluorescence measurement values ​​of each sample solution to the fluorescence measurement values ​​obtained here were calculated and used as the protein glycation rate (%).

[0041] The results of Test Example 1 are shown in Figure 1. As shown in Figure 1, it was confirmed that the rice bran enzyme-treated products of Production Examples 1 and 2 according to the present invention have a significantly superior inhibitory effect on the generation of advanced glycation end products (AGEs) compared to the rice bran enzyme-treated products of Comparative Production Examples 1 to 4. This suggests that the rice bran enzyme-treated products of Production Examples 1 and 2 according to the present invention can exert a cellular environment healthifying effect.

[0042] Test Example 2. Evaluation of enhanced activity of oxidative protein degrading enzymes In this test example, the effect of promoting the activity of oxidized protein hydrolase (OPH), an "acyl amino acid releasing enzyme" that breaks down oxidized proteins, was evaluated. First, human dermis-derived fibroblasts NB1RGB were cultured at 1 × 10 4 After pre-incubation for 1 day under conditions of 37°C and 5.0% CO2, the enzyme-treated product solution of Production Example 1 and the enzyme-treated product solutions of Comparative Production Examples 1 to 5 were added to the medium as sample solutions, and the medium was further cultured for 3 days under the same conditions. Here, each sample solution was added so that the final concentration of the solution was 2.0% relative to the amount of medium. Next, the medium was removed, 100 μL / well of 0.5% Triton X-100 solution was added, and the cells were disrupted by leaving the medium to stand for 5 minutes. Then, 50 μL / well of Ac-Ala-pNA (BACHEM L-1640) diluted with PBS (-) to 3 mM was added as a substrate, and the medium was incubated at 37°C for 3 hours. Then, the absorbance at 405 nm (ABS405 nm) was measured using a microplate reader (Model 680, Bio-Rad). The same procedure was also performed on wells in which cells were not seeded, and the OPH activity of each test group was determined by subtracting the ABS405nm value of the wells in which cells were not seeded from the ABS405nm value of each test group (ΔABS405nm). In addition, after the cells in a separate plate were cultured in the same manner as above, they were washed once with PBS(-), and 100 μL / well of hoechst33342 reagent diluted 100-fold with PBS(-) was added and incubated at 37°C for 1 hour to fluorescently stain DNA. Then, the fluorescence intensity (excitation: 355 nm, emission: 460 nm: fluorescence microplate reader (Fluoroscan Ascent, Thermo Fisher Scientific)) was measured to determine the amount of DNA. The OPH activity per cell was calculated by dividing the OPH activity value (ΔABS405 nm) of each sample addition group obtained here by the DNA amount (excitation: 355 nm, emission: 460 nm). The OPH activity per cell in each sample addition group was expressed as a relative value, with the OPH activity per cell value of the control group, to which PBS(-) was added instead of the sample solution, taken as 100.

[0043] 2, it was confirmed that the rice bran enzymatically treated products of Production Examples 1 and 2 according to the present invention have a significantly superior OPH activity enhancing effect compared to the rice bran enzymatically treated products of Comparative Production Examples 1 to 4. This confirmed that they have an effect of improving the cellular environment.

[0044] Formulation example 1. Lotion [Ingredients] Part Lavender oil 1.0 Glyceryl Caprylate 3.0 Polyglyceryl-10 Lauryl Acid 3.0 Methylparaben 0.1 Production Example 1 Enzyme-treated rice bran 2.0 White ginseng extract 2.0 Fermented ginseng extract 2.0 Fermented sweet potato extract 1.0 Guava Leaf Extract 1.0 Water-soluble collagen 1.0 Hydrolyzed Collagen 1.0 Eggplant extract 1.0 Strawberry Flower Extract 1.0 Glycerin 2.0 1,3-Butylene glycol 5.0 Sodium citrate 0.2 Purified water (enough to make the total amount 100 parts)

[0045] Formulation example 2: Lotion A lotion was obtained with the same composition as Formulation Example 1, except that the rice bran enzyme-treated product of Production Example 1 in Production Example 2 was used in place of the rice bran enzyme-treated product of Production Example 1 in Formulation Example 1 above.

[0046] Formulation example 3. Emulsion [Ingredients] Part Squalane 5.0 Hexalan 3.0 Wild rose oil 1.0 Camellia oil 1.5 Polyglyceryl Laurate 1.0 Lipophilic glyceryl stearate 1.0 Bisabolol 1.0 Behenyl Alcohol 3.0 Hydrogenated soy lecithin 1.5 Production Example 1 Enzyme-treated rice bran 2.0 White ginseng extract 2.0 Fermented ginseng extract 2.0 L-Ascorbic acid-2-glucoside 2.0 Fermented sweet potato extract 1.0 Shell Ginger Leaf Extract 1.0 Guava Leaf Extract 1.0 Licorice extract 1.0 Parthenium ginseng hydrolyzed extract 1.0 Water-soluble collagen 1.0 Hydrolyzed Collagen 1.0 Potassium hydroxide 0.5 Glycerin 3.0 1,3-Butylene glycol 2.0 Carboxymethylcellulose 0.3 Xanthan gum 0.2 Sodium hyaluronate 0.01 Purified water (enough to make the total amount 100 parts)

[0047] Formulation example 4. Emulsion An emulsion was obtained with the same composition as in Formulation Example 1, except that the rice bran enzyme-treated product of Production Example 1 in Production Example 2 was used in place of the rice bran enzyme-treated product of Production Example 1 in Formulation Example 3 above.

[0048] Formulation example 5. Emulsion An emulsion was obtained with the same composition as in Formulation Example 4, except that tranexamic acid (1.0 part) was used in place of L-ascorbic acid-2-glucoside and potassium hydroxide used in Formulation Example 3 above.

[0049] Formulation example 6. Emulsion An emulsion was obtained with the same composition as in Formulation Example 4, except that arbutin (3.0 parts) was used in place of L-ascorbic acid-2-glucoside and potassium hydroxide used in Formulation Example 3 above.

[0050] Formulation example 7. Emulsion An emulsion was obtained with the same composition as in Formulation Example 4, except that nicotinamide (3.0 parts) was used in place of L-ascorbic acid-2-glucoside and potassium hydroxide used in Formulation Example 3 above.

[0051] Formulation example 8. Cream [Ingredients] Part Olive oil 5.0 Jojoba oil 5.0 Meadowfoam Oil 5.0 Squalane 5.0 Behenyl Alcohol 2.0 Palmitic acid 2.5 Lactic acid fermented rice 2.0 Hydrogenated Lecithin 0.5 Glyceryl stearate 3.0 Production Example 1 Enzyme-treated rice bran 2.0 White ginseng extract 2.0 Fermented ginseng extract 2.0 Fermented sweet potato extract 1.0 Shell Ginger Leaf Extract 1.0 Guava Leaf Extract 1.0 Hydrolyzed Rice Extract 2.0 Water-soluble collagen 1.0 Hydrolyzed Collagen 1.0 Xanthan gum 1.0 Purified water (enough to make the total amount 100 parts)

[0052] Formulation example 9. Cream A cream was obtained with the same composition as Formulation Example 8, except that the rice bran enzyme-treated product of Production Example 1 in Production Example 2 was used in place of the rice bran enzyme-treated product of Production Example 1 in Formulation Example 8 above.

[0053] Formulation example 10. Facial cleanser [Ingredients] Part Coconut oil 2.0 Stearyl stearate 2.0 Glyceryl Caprylate 2.0 Enzyme-treated product of Production Example 1 2.0 White ginseng extract 2.0 Fermented ginseng extract 2.0 Water-soluble collagen 1.0 Glycerin 2.0 Fig Bark Extract 1.0 Job's Tears Seed Extract 1.0 Clove Extract 1.0

Claims

1. An inhibitor of the generation of advanced glycation end products, the active ingredient of which is rice bran with a polishing rate of 90% or more treated with proteolytic enzymes.

2. An oxidative protease activity enhancer containing as an active ingredient a protease-treated product of rice bran with a polishing rate of 90% or more.

Citation Information

Patent Citations

  • Water-soluble antioxidant

    JP1987241985A

  • cosmetic

    JP1990053705A

  • Cosmetic prepared from rice bran

    JP1995242531A

  • Method for producing antioxidant composition and health food

    JP2012214452A

  • Composition for biological defense and use thereof

    JP2017149692A